"JavaScript is a standard programming language that is included to provide interactive features, Kindly enable Javascript in your browser. For details visit help page"
भारत सरकार
Government of india
रसायन और उर्वरक मंत्रालय
Ministry of Chemicals and Fertilizers
Skip to main content
Search
The Web
PHARMACEUTICALS.GOV.IN
Search
A
+
A
A
-
A
A
Language
हिन्दी
Site Logo
औषध विभाग
Department of
Pharmaceuticals
Menu
Home
About Us
About the Department
Business Allocation
Divisions
Policy (Pharmaceuticals)
Policy (Medical Devices)
Jan Aushadhi
Policy (Pricing)
International Cooperation
Foreign Direct Investment
National Institutes of Pharmaceutical Education and Research (NIPERs)
Integrated Finance Division and Budget
Public Sector Undertakings (PSU)
Rajbhasha
Parliament & Coordination
Establishment
Vigilance
Administration
Agencies Under Department
Who's Who
Organisation Chart
Precedent Book
Procurement Projections
Citizen Charter
RTI
RTI - ACT
CPIO'S
Proactive Disclosure
Auditor's Report
RTI-Online Application/ Appeal
Work Allocation and Committees
Channel of Submission
Acts
Niper Act, Rules, Statutes & Ordinance
Drugs (Prices Control) Order, 2013
Policies
Schemes
PRIP
Others
Finance & Budget
Chief Controller Of Accounts
Plan Schemes
Budget and Expenditure
Detailed Demand for Grants
Swachh Bharat
Reports
Annual Report
Study Report
Home Slider
Content
Home
>
News
Documents/ Reports
Tenders
Recruitment
MOUs with PSUs
Media Gallery
Study Reports
Other Links
Review Orders
Annual Report
Important Links
Press Information Bureau
Hindi Shabdawali
STQC Certificate
Natco set for US launch of generic copy of Tevas drugg
Natco set for US launch of generic copy of Teva’s drug
Attachment File:
Download (38.25 KB)
Aurobindo acquires actavis
Aurobindo acquires actavis
Attachment File:
Download (18.39 KB)
Sun Pharma to face challenges in rectifying quality control
Sun Pharma to face challenges in rectifying quality control
Attachment File:
Download (87.11 KB)
From a drug distributor to global pharma tycoon
From a drug distributor to global pharma tycoon
Attachment File:
Download (51.44 KB)
We are going to retain Ranbaxy brand wherever it is strong
We are going to retain Ranbaxy brand wherever it is strong
Attachment File:
Download (74.67 KB)
US approvals key to Glenmarks prospects
US approvals key to Glenmark's prospects
Attachment File:
Download (92.48 KB)
Will cancel Ranbaxy stock taken by Silverstreet once it is issued
Will cancel Ranbaxy stock taken by Silverstreet once it is issued
Attachment File:
Download (105.42 KB)
Ranbaxy brand phaseout likely
Ranbaxy brand phaseout likely
Attachment File:
Download (25.17 KB)
Sun Pharma denies insider trading charges in Ranbaxy deal
Sun Pharma denies insider trading charges in Ranbaxy deal
Attachment File:
Download (66.72 KB)
EU exports to remain suspended
EU exports to remain suspended
Attachment File:
Download (59.34 KB)
Pages
« first
‹ previous
…
56
57
58
59
60
61
62
63
64
…
next ›
last »
Featured